Patents by Inventor Gayani Perera

Gayani Perera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230125057
    Abstract: This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases affected by glycolytic generation of adenosine triphosphate (ATP). More particularly, this disclosure relates to compounds and pharmaceutical compositions thereof, methods of selectively inhibiting glycolysis with these compounds, and methods of treating diseases that benefit from selective glycolysis inhibition, such as cancer.
    Type: Application
    Filed: January 7, 2021
    Publication date: April 20, 2023
    Inventors: Wesley C. VAN VOORHIS, Dustin James MALY, Kayode K. OJO, Gayani PERERA, Stephen R. PLYMATE, Cynthia SPRENGER, Takuma UO, Rama Subba Rao VIDADALA
  • Patent number: 11613544
    Abstract: Described herein, inter alia, are certain substituted imidazo[1,5-a]pyrazines of formula (I) and methods of using the same for modulating the activity of Ire1.
    Type: Grant
    Filed: September 24, 2020
    Date of Patent: March 28, 2023
    Assignees: The Regents of the University of California, University of Washington Through Its Center For Commercialization
    Inventors: Bradley J. Backes, Dustin J. Maly, Scott A. Oakes, Feroz R. Papa, Gayani Perera, Likun Wang
  • Publication number: 20210155626
    Abstract: Described herein, inter alia, are compositions and methods of using the same for modulating the activity of Ire1.
    Type: Application
    Filed: September 24, 2020
    Publication date: May 27, 2021
    Inventors: Bradley J. Backes, Dustin J. Maly, Scott A. Oakes, Feroz R. Papa, Gayani Perera, Likun Wang
  • Patent number: 10822340
    Abstract: Described herein, inter alia, are certain substituted imidazolopyrazines of formula (I) and methods of using the same for modulating the activity of Ire1.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: November 3, 2020
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
    Inventors: Bradley J. Backes, Dustin J. Maly, Scott A. Oakes, Feroz R. Papa, Gayani Perera, Likun Wang
  • Publication number: 20190084989
    Abstract: Described herein, inter alia, are compositions and methods of using the same for modulating the activity of Ire1.
    Type: Application
    Filed: October 2, 2018
    Publication date: March 21, 2019
    Inventors: Bradley J. Backes, Dustin J. Maly, Scott A. Oakes, Feroz R. Papa, Gayani Perera, Likun Wang
  • Patent number: 10131668
    Abstract: Described herein, inter alia, are compositions and methods of using the same for modulating the activity of Ire1 using for example, substituted imidazopyrazine compounds.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: November 20, 2018
    Assignees: The Regents of the University of California, University of Washington Through Its Center For Commercialization
    Inventors: Bradley J. Backes, Dustin J. Maly, Scott A. Oakes, Feroz R. Papa, Gayani Perera, Likun Wang
  • Publication number: 20160024094
    Abstract: Described herein, inter alia, are compositions and methods of using the same for modulating the activity of Ire1.
    Type: Application
    Filed: March 26, 2015
    Publication date: January 28, 2016
    Inventors: Bradley J. Backes, Dustin J. Maly, Scott A. Oakes, Feroz R. Papa, Gayani Perera, Likun Wang